Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deramiocel in myocardial infarction
NCT01458405Phase 2Terminated
- Sponsor
- Capricor Therapeutics
- Start
- Nov 2012
- Primary completion
- Jul 2017
- Modality
- Mesenchymal Stem Cells, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of deramiocel in myocardial infarction (MI), sponsored by Capricor Therapeutics. Started Nov 2012; status: terminated.
02
Drugs
deramiocel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01458405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458405.